Product logins

Find logins to all Clarivate products below.


: Rare diseases

Here you will find relevant articles and insight into all Clarivate related products and news.

The role of artificial intelligence or machine learning in conducting systematic literature reviews now and in future The role of artificial intelligence or machine learning in conducting systematic literature reviews now and in future
Blog June 21, 2024
The role of artificial intelligence or machine learning in conducting systematic literature reviews now and in future
Clinical research Clinical trials corporate
These seven ADC makers are developing therapies that show promise for hard-to-treat cancers These seven ADC makers are developing therapies that show promise for hard-to-treat cancers
Blog June 17, 2024
These seven ADC makers are developing therapies that show promise for hard-to-treat cancers
Clinical research Early drug development research Oncology
Indication Expansion: Pioneering new uses for existing cancer drugs Indication Expansion: Pioneering new uses for existing cancer drugs
Blog May 31, 2024
Indication Expansion: Pioneering new uses for existing cancer drugs
Clinical research Clinical trials Consulting Resource Center
Pharma is placing bigger bets on fewer, more strategic assets and platforms Pharma is placing bigger bets on fewer, more strategic assets and platforms
Blog May 8, 2024
Pharma is placing bigger bets on fewer, more strategic assets and platforms
Oncology Pharma Portfolio strategy
Unleashing the power of computational tools in rare disease Unleashing the power of computational tools in rare disease
Blog February 28, 2024
Unleashing the power of computational tools in rare disease
Clinical trials Pharma Portfolio strategy
Unlocking the potential of AI and machine learning for the life sciences Unlocking the potential of AI and machine learning for the life sciences
Blog February 5, 2024
Unlocking the potential of AI and machine learning for the life sciences
AI Resources Digital health Pharma
What sets the Drugs to Watch in 2024 apart What sets the Drugs to Watch in 2024 apart
Blog January 8, 2024
What sets the Drugs to Watch in 2024 apart
Clinical trials Mainland China Oncology
How clinical outcome assessments can help us understand the patient experience How clinical outcome assessments can help us understand the patient experience
Blog November 13, 2023
How clinical outcome assessments can help us understand the patient experience
Alopecia Clinical research Clinical trials

Rare diseases

온디맨드 웨비나 사이트런칭 온디맨드 웨비나 사이트런칭
Blog March 15, 2022
온디맨드 웨비나 사이트런칭
The role of artificial intelligence or machine learning in conducting systematic literature reviews now and in future The role of artificial intelligence or machine learning in conducting systematic literature reviews now and in future
Blog June 21, 2024
The role of artificial intelligence or machine learning in conducting systematic literature reviews now and in future
These seven ADC makers are developing therapies that show promise for hard-to-treat cancers These seven ADC makers are developing therapies that show promise for hard-to-treat cancers
Blog June 17, 2024
These seven ADC makers are developing therapies that show promise for hard-to-treat cancers
Indication Expansion: Pioneering new uses for existing cancer drugs Indication Expansion: Pioneering new uses for existing cancer drugs
Blog May 31, 2024
Indication Expansion: Pioneering new uses for existing cancer drugs
Pharma is placing bigger bets on fewer, more strategic assets and platforms Pharma is placing bigger bets on fewer, more strategic assets and platforms
Blog May 8, 2024
Pharma is placing bigger bets on fewer, more strategic assets and platforms
Unleashing the power of computational tools in rare disease Unleashing the power of computational tools in rare disease
Blog February 28, 2024
Unleashing the power of computational tools in rare disease
Unlocking the potential of AI and machine learning for the life sciences Unlocking the potential of AI and machine learning for the life sciences
Blog February 5, 2024
Unlocking the potential of AI and machine learning for the life sciences
What sets the Drugs to Watch in 2024 apart What sets the Drugs to Watch in 2024 apart
Blog January 8, 2024
What sets the Drugs to Watch in 2024 apart
How clinical outcome assessments can help us understand the patient experience How clinical outcome assessments can help us understand the patient experience
Blog November 13, 2023
How clinical outcome assessments can help us understand the patient experience
Five points on CMS's first ten picks for price negotiations Five points on CMS's first ten picks for price negotiations
Blog October 25, 2023
Five points on CMS's first ten picks for price negotiations
Four key points on the Inflation Reduction Act Four key points on the Inflation Reduction Act
Blog August 8, 2023
Four key points on the Inflation Reduction Act